Establishment Labs Holdings Inc (ESTA)
37.51
-1.81
(-4.60%)
USD |
NASDAQ |
Nov 14, 16:00
37.51
0.00 (0.00%)
After-Hours: 20:00
Establishment Labs Holdings Enterprise Value: 1.286B for Nov. 13, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2024 | 1.286B |
| November 12, 2024 | 1.374B |
| November 11, 2024 | 1.423B |
| November 08, 2024 | 1.448B |
| November 07, 2024 | 1.500B |
| November 06, 2024 | 1.520B |
| November 05, 2024 | 1.494B |
| November 04, 2024 | 1.462B |
| November 01, 2024 | 1.425B |
| October 31, 2024 | 1.360B |
| October 30, 2024 | 1.412B |
| October 29, 2024 | 1.409B |
| October 28, 2024 | 1.406B |
| October 25, 2024 | 1.403B |
| October 24, 2024 | 1.409B |
| October 23, 2024 | 1.412B |
| October 22, 2024 | 1.418B |
| October 21, 2024 | 1.324B |
| October 18, 2024 | 1.327B |
| October 17, 2024 | 1.337B |
| October 16, 2024 | 1.355B |
| October 15, 2024 | 1.344B |
| October 14, 2024 | 1.309B |
| October 11, 2024 | 1.268B |
| October 10, 2024 | 1.239B |
| Date | Value |
|---|---|
| October 09, 2024 | 1.310B |
| October 08, 2024 | 1.343B |
| October 07, 2024 | 1.447B |
| October 04, 2024 | 1.420B |
| October 03, 2024 | 1.324B |
| October 02, 2024 | 1.404B |
| October 01, 2024 | 1.289B |
| September 30, 2024 | 1.365B |
| September 27, 2024 | 1.454B |
| September 26, 2024 | 1.290B |
| September 25, 2024 | 1.254B |
| September 24, 2024 | 1.250B |
| September 23, 2024 | 1.261B |
| September 20, 2024 | 1.325B |
| September 19, 2024 | 1.368B |
| September 18, 2024 | 1.322B |
| September 17, 2024 | 1.356B |
| September 16, 2024 | 1.387B |
| September 13, 2024 | 1.374B |
| September 12, 2024 | 1.321B |
| September 11, 2024 | 1.285B |
| September 10, 2024 | 1.335B |
| September 09, 2024 | 1.321B |
| September 06, 2024 | 1.301B |
| September 05, 2024 | 1.327B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
186.83M
Minimum
Mar 18 2020
2.067B
Maximum
Jul 01 2021
1.275B
Average
1.434B
Median
Enterprise Value Benchmarks
| Bristol-Myers Squibb Co | 160.18B |
| Cassava Sciences Inc | 1.063B |
| Aytu BioPharma Inc | 5.853M |
| enVVeno Medical Corp | 11.24M |
| Onconetix Inc | 22.53M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -16.68M |
| Revenue (Quarterly) | 40.23M |
| Total Expenses (Quarterly) | 53.37M |
| EPS Diluted (Quarterly) | -0.59 |
| Gross Profit Margin (Quarterly) | 63.93% |
| Profit Margin (Quarterly) | -41.47% |
| Earnings Yield | -6.88% |
| Normalized Earnings Yield | -6.878 |